Zoeller JJ, Vagodny A, Daniels VW, Taneja K, et al. Navitoclax enhances the effectiveness of EGFR-targeted antibody-drug conjugates in PDX models of EGFR-expressing triple-negative breast cancer. Breast Cancer Res 2020;22:132.
PMID: 33256808